Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the corifact market grown over the years?

In recent years, the corifact market size has exhibited an HCAGR of XX. The market is projected to expand from $XX million in 2024 to $XX million in 2025, showcasing a compound annual growth rate (CAGR) of XX%. The growth observed in the historic timeframe can be linked to a higher usage of factor XIII concentrates, enhanced awareness, advanced automation, the need for extended care delivery, and the acceptance of novel plasma fractionation technologies.

What Is the forecasted market size and growth rate for the corifact market?

The market size of Corifact is predicted to experience an XX% (FCAGR) uptick over the upcoming years, reaching a projected value of $XX million in 2029. This significant rise is attributed to the increasing incidence of bleeding disorders, heightened awareness and early detection, an increase in surgical operations, a growing dependency on client base, and the elongated half-life of factor VIII. Notable trends over this forecast period including technological progress, improvements in healthcare infrastructure, innovative methodologies in developing recombinant therapies, advances in biotechnology, and the FDA’s approval of Corifact.

Get your corifact market report here!

https://www.thebusinessresearchcompany.com/report/corifact-global-market-report

What are the major factors driving growth in the corifact market?

The escalating incidence of blood clotting disorders is predicted to fuel the corifact market’s expansion. These disorders, which hinder the blood’s clotting ability, result in prolonged or excessive bleeding. Enhanced diagnostic techniques, greater awareness, advancements in genetic tests, lifestyle modifications, and the presence of contributory conditions are all factors contributing to the surge in clotting disorders. Corifact is used to manage blood clotting disorders stemming from a deficiency in factor XIII by replacing the absent clotting agent, thus aiding in the formation of stable clots and minimizing excessive bleeding. For instance, a World Federation of Hemophilia Report published in October 2023 revealed that in 2022, a whopping 427,685 individuals across the globe were diagnosed with clotting disorders. The statistics included 257,146 hemophilia cases- 208,957 hemophilia A, 42,203 hemophilia B, and 5,986 unspecified types. Additionally, there were 100,505 cases of von Willebrand disease and 70,034 instances of other clotting disorders. Therefore, the escalating incidence of these disorders is facilitating the corifact market’s growth.

What key areas define the segmentation of the global corifact Market?

The corifact market covered in this report is segmented –

1) By Product: Human-Derived Factor XIII, Recombinant Factor XII

2) By Therapeutic Applications: Routine Prophylactic Treatment, Peri-Operative Management

3) By Distribution Channels: Hospital Pharmacies, Specialty Pharmacies, Outpatient Clinics

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20024&type=smp

What are the top market players propelling the growth of the corifact industry?

Major companies operating in the corifact market include CSL Behring

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20024

What regions are dominating the corifact market growth?

North America was the largest region in the corifact market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the corifact market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Encephalitis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/encephalitis-treatment-global-market-report

Epidural Abscess Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/epidural-abscess-treatment-global-market-report

Keloids Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/keloids-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: